Suchergebnisse - "Narvekar, Priya"

PubPharm (6)

1

Correction to : An in vitro Assessment of Thermo-Reversible Gel Formulation Containing Sunitinib Nanoparticles for Neovascular Age-Related Macular Degeneration

enthalten in: AAPS PharmSciTech | 2024

von Bhatt, P. | Narvekar, P. | Lalani, R. | +3

ErratumFor: AAPS PharmSciTech. 2019 Aug 9;20(7):281. - PMID 31399890

2

Correction to: An in vitro Assessment of Thermo-Reversible Gel Formulation Containing Sunitinib Nanoparticles for Neovascular Age-Related Macular Degeneration

enthalten in: AAPS PharmSciTech | 2024

von Bhatt, P. | Narvekar, P. | Lalani, R. | +3

3

An in vitro Assessment of Thermo-Reversible Gel Formulation Containing Sunitinib Nanoparticles for Neovascular Age-Related Macular Degeneration

enthalten in: AAPS PharmSciTech | 2019

von Bhatt, P. | Narvekar, P. | Lalani, R. | +3

ErratumIn: AAPS PharmSciTech. 2024 Mar 14;25(3):62. - PMID 38485865

4

An in vitro Assessment of Thermo-Reversible Gel Formulation Containing Sunitinib Nanoparticles for Neovascular Age-Related Macular Degeneration

enthalten in: AAPS PharmSciTech | 2019

von Bhatt, P. | Narvekar, P. | Lalani, R. | +3

5

An in vitro Assessment of Thermo-Reversible Gel Formulation Containing Sunitinib Nanoparticles for Neovascular Age-Related Macular Degeneration

enthalten in: AAPS PharmSciTech | 2019

von Bhatt, P. | Narvekar, P. | Lalani, R. | +3

6

Axitinib-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles for Age-Related Macular Degeneration : Formulation Development and In Vitro Characterization

enthalten in: Assay and drug development technologies | 2019

von Narvekar, P. | Bhatt, P. | Fnu, G. | +1

1
[1]